We are live on ! Find out more
PAHC icon

Phibro Animal Health

168 hedge funds and large institutions have $670M invested in Phibro Animal Health in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 63 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.17% more ownership

Funds ownership: 100.78%103.95% (+3.2%)

1% less capital invested

Capital invested by funds: $674M → $670M (-$4.54M)

8% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 63

5% less funds holding

Funds holding: 176168 (-8)

21% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 24

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $210K

Holders
168
Holders Change
-8
Holders Change %
-4.55%
% of All Funds
3.65%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
19
Increased
58
Reduced
63
Closed
24
Calls
Puts
$210K
Net Calls
-$210K
Net Calls Change
-$209K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$5.4M -$129K -4,115 -2%
Man Group
27
Man Group
United Kingdom
$5.39M -$231K -7,379 -4%
Bank of America
28
Bank of America
North Carolina
$5.37M +$1.81M +57,692 +52%
AQR Capital Management
29
AQR Capital Management
Connecticut
$5.19M -$1.51M -48,292 -23%
Invesco
30
Invesco
Georgia
$5.12M -$1.23M -39,090 -20%
CIP
31
Chartwell Investment Partners
Pennsylvania
$5.07M +$5M +159,481 New
Fidelity Investments
32
Fidelity Investments
Massachusetts
$5.04M -$5.61M -179,048 -53%
MAM
33
Martingale Asset Management
Massachusetts
$4.88M
Millennium Management
34
Millennium Management
New York
$4.6M -$1.42M -45,161 -24%
CIM
35
Confluence Investment Management
Missouri
$4.53M +$133K +4,234 +3%
MSL
36
Mackay Shields LLC
New York
$3.78M +$2.18M +69,392 +140%
Charles Schwab
37
Charles Schwab
California
$3.74M -$1.01M -32,109 -21%
Baird Financial Group
38
Baird Financial Group
Wisconsin
$3.68M +$2.86M +91,115 +370%
Citadel Advisors
39
Citadel Advisors
Florida
$3.06M -$1.69M -54,018 -36%
Marshall Wace
40
Marshall Wace
United Kingdom
$3.02M +$2.36M +75,277 +380%
Morgan Stanley
41
Morgan Stanley
New York
$2.85M -$4.29M -136,958 -60%
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$2.8M -$176K -5,614 -6%
CI
43
Cambiar Investors
Colorado
$2.77M -$490K -15,626 -15%
PCM
44
Polaris Capital Management
Massachusetts
$2.67M
QI
45
QS Investors
New York
$2.56M -$53.3K -1,700 -2%
OAM
46
Oxford Asset Management
United Kingdom
$2.55M -$273K -8,706 -10%
AllianceBernstein
47
AllianceBernstein
Tennessee
$2.31M +$329K +10,500 +17%
SDIC
48
South Dakota Investment Council
South Dakota
$2.1M
TAM
49
Tocqueville Asset Management
New York
$1.96M +$1.93M +61,608 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$1.95M +$75.2K +2,399 +4%

PAHC Hedge Fund Activity: Q2 2019 in Review

168 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2019, worth a combined $670M — down 0.67% from $674M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PAHC and 19 opened new positions — a net loss of 5 holders — while 63 trimmed existing stakes and 58 added.

The largest buyer was Fiduciary Management Inc, adding an estimated $25.9M. The largest seller was Fidelity Investments, cutting an estimated $5.61M.

  • 168 institutional investors held Phibro Animal Health (PAHC) as of Q2 2019, down from 176 in Q1 2019.
  • Funds reported $670M of Phibro Animal Health stock for Q2 2019, down 0.67% quarter-over-quarter.
  • 19 funds opened new Phibro Animal Health positions in Q2 2019 and 24 closed out, a net change of -5 holders.
  • The largest Phibro Animal Health buyer in Q2 2019 was Fiduciary Management Inc, an estimated $25.9M added.
  • The largest Phibro Animal Health seller in Q2 2019 was Fidelity Investments, an estimated $5.61M sold.

Based on aggregated 13F filings for Q2 2019.